Leeor Zilbermintz
Affiliations: | Keck Graduate Institute, Claremont, CA, United States |
Area:
Infectious Disease, Drug Discovery, Drug Host Interactions, Bacterial ToxinsGoogle:
"Leeor Zilbermintz"Parents
Sign in to add mentor| Leah Krubitzer | research assistant | 2011-2011 | UC Davis (Neurotree) |
| Peyman Golshani | grad student | 2012-2012 | David Geffen School of Medicine at UCLA (Neurotree) |
| Mikhail Martchenko | grad student | 2012-2017 | McGill |
| David Engman | post-doc | 2017- | Cedars-Sinai |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Brown RWB, Sharma AI, Villanueva MR, et al. (2022) Acyl-Protein Thioesterase-like (TbAPT-L) Is a Lipase with Esterase Activity for Short and Medium-Chain Fatty Acids but Has No Depalmitoylation Activity. Pathogens (Basel, Switzerland). 11 |
| Martchenko Shilman M, Bartolo G, Alameh S, et al. (2021) Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax. Acs Infectious Diseases |
| Zilbermintz L, Leonardi W, Tran SH, et al. (2016) Cross-inhibition of pathogenic agents and the host proteins they exploit. Scientific Reports. 6: 34846 |
| Leonardi W, Zilbermintz L, Cheng LW, et al. (2016) Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virus. Scientific Reports. 6: 34475 |
| Zilbermintz L, Leonardi W, Jeong SY, et al. (2015) Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting. Scientific Reports. 5: 13476 |
| Kim K, Zilbermintz L, Martchenko M. (2015) Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans. Annals of Clinical Microbiology and Antimicrobials. 14: 32 |
| Zilbermintz L, Leonardi W, Jeong SY, et al. (2015) Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting Scientific Reports. 5 |